AMRUBICIN THERAPY IMPROVES PATIENTS WITH REFRACTORY SMALL-CELL LUNG CANCER: A SINGLE-ARM CONFIRMATORY CHINESE CLINICAL STUDY

Amrubicin therapy improves patients with refractory small-cell lung cancer: A single-arm confirmatory Chinese clinical study

Our objective was to VEGAN FERMENTED PROTEIN UNFLAVOURED evaluate an open-label, multicenter, single-arm study to appraise whether amrubicin therapy improves patients with refractory small-cell lung cancer in Chinese clinical study.Patients (n=95) with refractory small-cell lung cancer received 3 consecutive days amrubicin therapy for 21 days.Overa

read more



Can learning be enhanced with active seating?

Overweightness continues to increase at an exponential rate in children.This coupled with the demand to increase academic time in elementary schools has contributed to efforts to discover solutions that meet both challenges.Potential solutions are movement curricula and active seating options.However, little has been published relative to best prac

read more